Feds Fund Addiction Meds to Keep Families Together

Thousands of parents struggling with opioid addiction will now have better access to medications that could help them keep their children out of foster care.

The Department of Health and Human Services announced this week that child welfare agencies can receive federal funding to cover half the cost of FDA-approved addiction treatments. The medications include buprenorphine, naltrexone, and methadone, which research shows are the most effective treatments for opioid use disorder.

More than 62,000 children entered foster care in 2024 because of factors related to drug use by a parent, caretaker, or prenatal exposure. Yet only a small fraction of parents with opioid addiction have been able to access these proven treatments, often due to stigma and strict prescribing rules.

Some parents were even investigated by social workers or had newborns removed simply because they were taking legally prescribed medications for their addiction. These barriers existed despite federal protections guaranteeing rights for patients with disabilities.

The new policy allows state and county child welfare agencies to seek federal reimbursement under Title IV-E of the Social Security Act. This means uninsured parents can now receive treatment that could prevent the need to remove their children from home.

"When we deny parents access to affordable, effective treatment for opioid addiction, we tear families apart," said Health Secretary Robert F. Kennedy Jr. "Using Title IV-E funding to provide life-saving medications keeps families together and moves our system toward recovery and prevention."

The change especially benefits rural communities and families without Medicaid coverage. Previously, Medicaid covered these treatments, but many parents fell through the cracks without insurance or faced waiting lists at overcrowded treatment centers.

The Ripple Effect

The policy shift marks the first time medications have been approved for foster care prevention under the 2018 Family First Prevention Services Act. That reform aimed to boost spending on keeping families together, but it had a slow start with most jurisdictions never submitting prevention claims.

Judge Anthony Capizzi, who recently retired from juvenile court in Ohio, said attitudes toward these medications have evolved dramatically. "For years, we thought it was a crutch, and we're finding that if we use this treatment modality, people can change," he explained. "We have evidence-based examples of how it works."

The Administration for Children and Families will provide tools and resources to help states integrate these prevention services into their plans. While it's up to individual states to accept the funding, advocates hope the destigmatization of these treatments will encourage widespread adoption.

For the thousands of families currently navigating the child welfare system, this policy change could mean the difference between staying together and years of painful separation.